Trends in breast cancer death rates from ductal carcinoma in situ versus invasive cancer in the United States | Breast Cancer Research
Data source and study participants To examine the trend in death rate from DCIS among women, we used…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…